Medical release archive
Here you can find the archive of all Medical releases prior to 2018
Filter by date:
Showing 30 medical releases before 2018
-
New England Journal of Medicine publishes results of Phase III FLAURA trial in the 1st-line treatment of EGFR-mutated non-small cell lung cancer
-
New data show benefit of Tagrisso in patients with EGFR-mutated non-small cell lung cancer and central nervous system metastases
-
Faslodex (fulvestrant) receives EU approval for the treatment of hormone receptor-positive advanced breast cancer in combination with palbociclib
-
ZS-9 (sodium zirconium cyclosilicate) Phase III long-term safety and efficacy data presented at ASN Kidney Week 2017
-
AstraZeneca and Chi-Med’s savolitinib shows encouraging clinical activity in EGFR mutation-positive lung cancer with MET-amplification
-
Forxiga DEPICT-1 trial demonstrates improved glycaemic control without increasing hypoglycaemia, lowered weight and total daily insulin dose in patients with type-1 diabetes
-
AstraZeneca presents new evidence on Symbicort (budesonide/formoterol) in COPD patients at risk of exacerbation
-
New data supports long-term efficacy of ticagrelor in patients up to five years following a heart attack
-
AstraZeneca presents Tagrisso (osimertinib) data in patients with EGFR T790M-mutation positive lung cancer and central nervous system metastases
-
Lynparza (olaparib) maintenance treatment offers sustained quality of life alongside improved progression-free survival in women with BRCA-mutated ovarian cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Rebecca Einhorn
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team